IDBS announced a partnership with the
Intellectual Property & Science division of Thomson Reuters to transform
how researchers access curated biological content and apply it to their
research workflow. With this partnership, the companies have integrated their
technology through the IDBS ScienceLink scientific content brokerage platform,
enabling researchers to access scientific content from Thomson Reuters Integrity,
combined with the intuitive delivery methods of the Cortellis Targets API from within E-WorkBook Suite.
ScienceLink, a feature of IDBS’ E-WorkBook
enterprise electronic laboratory notebook, allows customers to launch a single
query to search and retrieve data from internal systems and from leading
licensed external scientific data sources. Thomson Reuters Integrity is a source of reliable, detailed information gathered across
multiple disciplines that supports successful drug research and development. With the
integration, research teams can now search literature and curated sources
through the Cortellis for Informatics
Targets API directly within E-WorkBook. Where previously users
had to manually collate information, they can now integrate all their available
knowledge, accessing data seamlessly and exporting it back to E-WorkBook with a
single mouse click.
The combined solution will accelerate
biological research in areas such as target identification and validation,
experimental pharmacology, toxicology, and biomarker discovery. By bringing together all relevant information ‘just in
time’ and at the ‘point of use’, this search and delivery of biological
content ensures relevant information is available when and where it is needed
most, empowering researchers to make the most informed decisions.
Thomson Reuters, www.thomsonreuters.com
